FGFR2 and cancer: Small-molecule FGFR inhibitors, including PD173074, SU5402, AZD2171, and Ki23057, revealed advantageous properties to prevent cancer proliferation and progression in people with the FGFR2 risk allele through their detrimental activities to interfere with a cytoprotective mechanism against oxidative stress [45].